Search research articles
Contact Us
Filters
Showing results (181-190 of 218) with videos related to
Page
of 22
Sort By:
Blood Neoplasia
|
March 11, 2026
Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease
Christoph Weigel, Haley L Klimaszewski, Fode Tounkara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 23, 2008
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma
Lauri M Burroughs, Paul V O'Donnell, Brenda M Sandmaier, et al.
Blood
|
February 7, 2013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial
Jennifer A Kanakry, Hailun Li, Lan L Gellert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 22, 2020
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Philip H Imus, Hua-Ling Tsai, Amy E DeZern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
Philip H Imus, Amanda L Blackford, Maria Bettinotti, et al.
Transplantation and Cellular Therapy
|
August 23, 2021
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide
Katherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, et al.
Transplantation and Cellular Therapy
|
December 22, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source
Cole H Sterling, Michael S Hughes, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2009
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome
Yvette L Kasamon, Leo Luznik, Mary S Leffell, et al.
International Journal of Cancer
|
July 12, 2024
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations
Yomani D Sarathkumara, Rena R Xian, Zhiwei Liu, et al.
Transplantation and Cellular Therapy
|
November 7, 2025
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide
Amy E DeZern, Marianna Zahurak, Tyler Cavin, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 218) with videos related to
Sort By:
Page
of 22
Blood Neoplasia
|
March 11, 2026
Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease
Christoph Weigel, Haley L Klimaszewski, Fode Tounkara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 23, 2008
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma
Lauri M Burroughs, Paul V O'Donnell, Brenda M Sandmaier, et al.
Blood
|
February 7, 2013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial
Jennifer A Kanakry, Hailun Li, Lan L Gellert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 22, 2020
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Philip H Imus, Hua-Ling Tsai, Amy E DeZern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
Philip H Imus, Amanda L Blackford, Maria Bettinotti, et al.
Transplantation and Cellular Therapy
|
August 23, 2021
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide
Katherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, et al.
Transplantation and Cellular Therapy
|
December 22, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source
Cole H Sterling, Michael S Hughes, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 21, 2009
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome
Yvette L Kasamon, Leo Luznik, Mary S Leffell, et al.
International Journal of Cancer
|
July 12, 2024
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations
Yomani D Sarathkumara, Rena R Xian, Zhiwei Liu, et al.
Transplantation and Cellular Therapy
|
November 7, 2025
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide
Amy E DeZern, Marianna Zahurak, Tyler Cavin, et al.
Page
of 22